Loading stock data…
QDEL
$10.80+0.03 (+0.28%)
Market ClosedLast close May 8
QuidelOrtho Corporation provides diagnostic testing solutions.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
QuidelOrtho Corporation in the Healthcare sector is trading at $10.80. The stock is currently near its 52-week low of $10.21, remaining 55.8% below its 200-day moving average. Technical signals show neutral RSI of 34 and bullish MACD crossover, explaining why QDEL maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 34) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$10.80
Potential Upside
5%
Whystock Fair Value$11.34
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus5 analysts
Buy
Mean target$19.10+76.9%
Range$12.50 – $38.00
Fundamentals
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$810.17M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.92
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-24.29%
Volume
Today's trading volume
2.11M
Recent News
Oracle upgraded, Planet Fitness downgraded: Wall Street's top analyst calls
Oracle upgraded, Planet Fitness downgraded: Wall Street's top analyst calls
QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y
QuidelOrtho posts a wider Q1 loss as revenues fell 10.5% year over year, with weakness in respiratory testing pressuring margins and cash flow.
QuidelOrtho Q1 Earnings Call Highlights
QuidelOrtho (NASDAQ:QDEL) said its first-quarter 2026 results were pressured by a meaningfully weaker respiratory season, distributor caution in China ahead of expected national IVD pricing guidelines, and some order delays tied to Middle East disruptions, while management reiterated expectations fo
QuidelOrtho Corporation Q1 2026 Earnings Call Summary
Moby summary of QuidelOrtho Corporation's Q1 2026 earnings call
QuidelOrtho (QDEL) Q1 2026 Earnings Transcript
Need a quote from a Motley Fool analyst? With me are Brian J. Blaser, President and Chief Executive Officer, and Joseph M. Busky, Chief Financial Officer. To assist in the presentation, we also posted supplemental information on our Investor Relations page that will be referenced in this call.